Viewing nowOmexil Tablet 40mg (Olmesartan Medoxomil)
Olmesartan Medoxomil 40mg
Tablet · Prescription medication
Ajou Pharmaceutical Co., Ltd.

MFDS item code 201900103 · Approved 2019.01.09 · Insurance code 654005230
Treatment of essential hypertension
Essential hypertension refers to a condition where blood pressure is consistently high without a specific cause. This medicine lowers blood pressure, thereby reducing the burden on the heart and blood vessels. It helps to lower the risk of complications such as myocardial infarction and stroke through the management of hypertension. The treatment effect is enhanced when used consistently along with lifestyle improvement. It is used safely and effectively for the treatment of essential hypertension.
<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If additional blood pressure reduction is required, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment, with the maximum effect occurring at approximately 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered concomitantly with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time each day (e.g., in the morning), if possible. For patients who may have decreased effective intravascular volume (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. <Elderly patients> No dose adjustment is required when this drug is administered to patients aged 65 years or older. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is required for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, which may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this drug is not recommended.
The safety and efficacy in pediatric patients have not been established.
This medication can cause serious harm or death to the fetus and newborn if taken during the second or third trimester of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Individuals allergic to any component of this medication, pregnant or breastfeeding women, patients on renal dialysis, patients with severe liver disease, patients with biliary obstruction, and certain genetically lactose intolerant patients should not take this medication. Patients with decreased blood volume or sodium may experience low blood pressure; therefore, the condition should be well assessed before starting treatment, and if symptoms of low blood pressure occur, appropriate measures should be taken immediately. Patients with impaired renal function, kidney transplant recipients, patients with renovascular hypertension, and patients at risk of hyperkalemia should also use this medication cautiously and should regularly check renal function and electrolyte status through blood tests. Patients with aortic or mitral valve stenosis, obstruction, and hypertrophic cardiomyopathy should take this medication with special caution. This medication may cause side effects such as dizziness, so it is advisable to avoid hazardous activities such as working at heights or driving. Although it is generally safe to use, various side effects can occur, such as dizziness, headache, gastrointestinal discomfort, hyperkalemia, blood pressure changes, etc., and any unusual symptoms should be consulted with a healthcare professional. When taken with other antihypertensive agents or potassium-sparing diuretics, or potassium supplements, there may be an increase in serum potassium levels, so caution is required when used in combination. Taking with lithium preparations may increase lithium levels and lead to toxicity, therefore concurrent use of this medication and lithium is not recommended. Caution is needed when used in combination with nonsteroidal anti-inflammatory drugs due to the risk of renal function impairment; regular hydration and renal function checks are necessary during the course of treatment. This medication is not administered to pregnant women due to the severe risk of fetal harm and alternative treatments should be considered during pregnancy. Breastfeeding women should discontinue nursing or stop taking this medication as it may pass into breast milk and cause adverse reactions in infants. Safety and efficacy in pediatric patients have not yet been established, so it should be used cautiously in children. Elderly patients may experience higher body levels of this medication, hence dose adjustment and caution are necessary. Overdose may indicate symptoms such as low blood pressure and palpitations; if these symptoms occur, immediate treatment from medical professionals is necessary. This medication has been reported to have a low risk of carcinogenic or genotoxic effects even after prolonged use; however, it is crucial to discuss with healthcare professionals before and after administration.
Dizziness, chest pain, peripheral edema, lightheadedness, abdominal pain, dyspepsia, gastroenteritis, nausea, palpitation, hypercholesterolemia, hyperlipidemia, hyperuricemia, arthralgia, arthritis, myalgia, rash, facial swelling, weakness, angioedema, anaphylactic reaction, vomiting, chronic malabsorption syndrome - similar intestinal diseases, intestinal vascular edema, rhabdomyolysis, hyperkalemia, acute kidney failure, elevated serum creatinine, hair loss, pruritus, urticaria, autoimmune hepatitis, headache, increased blood pressure, nosebleed, upper respiratory tract infection, asthma, cough
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a tightly sealed container to prevent exposure to air or moisture. It is advisable to keep it at room temperature between 1 and 25 degrees Celsius.
White oblong film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowOlmesartan Medoxomil 40mg
Tablet · Prescription medication
Ajou Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Jongkeundang Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.